Content deleted Content added
Ozzie10aaaa (talk | contribs) |
Ozzie10aaaa (talk | contribs) |
||
Line 203:
Traditionally, [[tricyclic antidepressants]] (TCAs), such as [[nortriptyline]], have been used in the treatment of post-stroke depression. More recently, the [[selective serotonin reuptake inhibitors]] (SSRIs), such as [[fluoxetine]] and [[citalopram]], have become the pharmacologic therapy of choice due to the lower incidence of [[adverse effect|side effects]]. Also, psychologic treatment such as [[cognitive behavioral therapy]], [[group therapy]], and [[family therapy]] are reported to be useful adjuncts to treatment.{{cn}}
Overall, the development of post-stroke depression can play a significant role in a patient's recovery from a stroke. The severity of post-stroke depression has been associated with severity of impairment in [[activities of daily living]] (ADLs). By effectively treating depression, patients experience a greater recovery of basic ADLs such as dressing, eating and ambulating, as well as instrumental ADLs, such as the ability to take care of financial and household matters. In essence, recognition and treatment of post-stroke depression leads to greater functional ability for the patient over time.{{cn}}
== Cognitive Impairment and Therapy ==
| |||